Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease

Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide. Development of DKD increases risks for cardiovascular events and death. Glucagon-like peptide-1 (GLP-1) receptor agonist have demonstrated improved cardiovascular and kidney outcomes in large-scale clinical trials. RECEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Alicic, Radica Z., Neumiller, Joshua J., Tuttle, Katherine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
RENAL PATHOPHYSIOLOGY: Edited by Orson W. Moe and Susan Quaggin
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241427/
https://www.ncbi.nlm.nih.gov/pubmed/37195250
http://dx.doi.org/10.1097/MNH.0000000000000894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241427/
https://www.ncbi.nlm.nih.gov/pubmed/37195250
http://dx.doi.org/10.1097/MNH.0000000000000894

Ejemplares similares